13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

The 13th Annual International Symposium on Melanoma and Other Cutaneous Malignancies® is a 1-day educational and scientific meeting that will focus on contemporary approaches in the management of melanoma and other cutaneous malignancies, as well as future directions in therapy.

The field of skin cancer treatment has been at the forefront in oncology in recent times, and has been a major focus of novel drug development. In particular, the advent of targeted and immunotherapeutic approaches to manage these malignancies has transformed care, in recent years. There are also many investigational strategies in late-stage development, and these promise to further change practice in 2017. This is great news for patients, but also challenges busy clinicians to maintain state-of-the-art approaches in their practices.

This year’s program, led by world-class experts Omid Hamid, MD and Jeffrey Weber, MD, PhD, will focus on a number of core areas that are key to personalizing care for these tumors in contemporary practices settings, including sessions on immunotherapies, targeted therapies, regional therapy, predictive/prognostic modeling, and integrated medicine/patient care. This fast-paced, highly practical, and interactive forum will once again provide physicians who treat patients with skin cancer unique access to renowned international experts in the management of these tumors.

Approved for AMA PRA Category 1 Credits™